New Breast Cancer Drug Approval!
Sources: US Food & Drug Safety Administration; MedScape Pertuzumab ( Perjeta, Genentech/Roche), has been approved in the United States. Perjeta targets HER2-positive breast cancer. About 1/4 of all cases of breast cancer are HER2-positive. It is indicated for use in patients with metastatic HER2-positive breast cancer who have not received previous treatment with either chemotherapy or [...]